{"nct_id":"NCT02743546","title":"Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma","status":"WITHDRAWN","status_verified_date":"2025-01","start_date":"2016-07-20","start_date_type":"ESTIMATED","primary_completion_date":"2018-09-30","primary_completion_date_type":"ESTIMATED","completion_date":"2020-03-31","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["JNJ"]}